Hu, F.; Hu, C.; He, Y.; Sun, Y.; Han, C.; Zhang, X.; Yu, L.; Shi, D.; Sun, Y.; Zhang, J.;
et al. TLR7: A Key Prognostic Biomarker and Immunotherapeutic Target in Lung Adenocarcinoma. Biomedicines 2025, 13, 151.
https://doi.org/10.3390/biomedicines13010151
AMA Style
Hu F, Hu C, He Y, Sun Y, Han C, Zhang X, Yu L, Shi D, Sun Y, Zhang J,
et al. TLR7: A Key Prognostic Biomarker and Immunotherapeutic Target in Lung Adenocarcinoma. Biomedicines. 2025; 13(1):151.
https://doi.org/10.3390/biomedicines13010151
Chicago/Turabian Style
Hu, Feiming, Chenchen Hu, Yuanli He, Yuanjie Sun, Chenying Han, Xiyang Zhang, Lingying Yu, Daimei Shi, Yubo Sun, Junqi Zhang,
and et al. 2025. "TLR7: A Key Prognostic Biomarker and Immunotherapeutic Target in Lung Adenocarcinoma" Biomedicines 13, no. 1: 151.
https://doi.org/10.3390/biomedicines13010151
APA Style
Hu, F., Hu, C., He, Y., Sun, Y., Han, C., Zhang, X., Yu, L., Shi, D., Sun, Y., Zhang, J., Jiang, D., Yang, S., & Yang, K.
(2025). TLR7: A Key Prognostic Biomarker and Immunotherapeutic Target in Lung Adenocarcinoma. Biomedicines, 13(1), 151.
https://doi.org/10.3390/biomedicines13010151